Routine credit facility extension with no new borrowing. Monitor future 10-Q for any draw-downs or changes in leverage, but this filing alone does not signal a change in financial health or investment thesis.
Price Chart
Executive Summary
IGC Pharma extended its existing Master Loan and Security Agreement with O-Bank Co., Ltd., maintaining a $12,000,000 credit facility. The facility fee increased from $48,000 to $60,000, but all other material terms remain substantially unchanged from the prior year's agreement. This is a routine continuation of a credit facility with no new borrowing or change in terms that would materially impact the company's financial position.
Key Financial Metrics
Key Facts
- IGC Pharma entered into an amendment to extend its existing Master Loan and Security Agreement with O-Bank Co., Ltd., dated June 5, 2026.
- The facility provides for a maximum aggregate limit of $12,000,000.
- Material terms remain substantially unchanged from the 2025 facility letter.
- The facility fee increased from $48,000 to $60,000.
- No new borrowing was announced; this is a continuation of existing credit arrangements.
Financial Impact
Extension of $12,000,000 credit facility with a modest $12,000 increase in annual facility fee. No new debt drawn or material change in obligations.
Risk Factors
- Interest rate terms or covenants were not disclosed and could change upon renewal or draw.
- Reliance on a single Taiwan-based lender for credit capacity.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001185185-26-002410 |
| Document: 0001185185-26-002410-index-headers.html | 0001185185-26-002410 |
| Document: 0001185185-26-002410-index.html | 0001185185-26-002410 |
| Document: 0001185185-26-002410.txt | 0001185185-26-002410 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 3d ago | DEFA14A | $0.2434 | awaiting T+60 | — | $0.2500 (+2.71%) |
Oct 21, 2026 4d ago | DEF 14A | $0.2500 | awaiting T+60 | — | $0.2500 (0.00%) |
Jul 6, 2026 15w ago | 8-K | $0.2780 $0.2689 | ▼ −3.27% | ▼ −5.27% | $0.2500 (−10.07%) |
Jun 8, 2026 19w ago | 8-K | $0.2850 $0.2985 | ▲ +4.74% | ▼ −0.16% | $0.2500 (−12.28%) |
Apr 20, 2026 26w ago | 8-K | $0.3200 $0.2563 | ▲ +19.91% | ▲ +26.81% | $0.2500 (+21.88%) |
Mar 12, 2026 32w ago | 8-K | $0.2800 $0.2900 | ▼ −3.57% | ▲ +7.13% | $0.2500 (+10.71%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers